PBS listing recommendation for psoriasis drug Ustekinumab (Stelara) has received a positive recommendation for PBS listing for the treatment of paediatric patients with severe chronic plaque psoriasis. At its March 2021 meeting the Pharmaceutical Benefits Advisory Committee said it was satisfied that ustekinumab provided a significant improvement in efficacy over etanercept. A PBS listing was ...
News in brief: PBS listing recommendation for psoriasis biologic; Eczema remains common in adults; First treatment to improve OS in metastatic uveal melanoma
4 May 2021